Protein maybe key to halting obesity related disease

January 24, 2014
Protein maybe key to halting obesity related disease
Australians are developing a form of liver disease seen in alcoholics – but which is being caused by obesity rather than an addiction to drink.

(Medical Xpress)—Australians are getting more obese and developing a disease called non-alcoholic fatty liver disease – a disease similar to that that results in cirrhosis in alcoholics and can be a precursor to diabetes.

Melbourne researchers have discovered a protein that may be key to the development of these diseases, providing a potential drug target that could act as a hand brake to the cascade of deadly diseases that can result from obesity.

Australians are developing a form of seen in alcoholics – but which is being caused by obesity rather than an addiction to drink. Non-alcoholic liver disease affects about 5.5 million Australians and one of the common risk factors for this condition is obesity. Nearly two thirds of obese adults and half of obese children are found to have fatty liver – which is a precursor to Type 2 diabetes.

Researchers at the Monash University School of Biomedical Sciences have discovered a novel protein that is released as a consequence of fatty liver and causes diabetes. The isolation of this new protein opens the way to developing drugs that can block the production of this protein potentially preventing the disease.

Professor Matthew Watt found more than three dozen proteins that are secreted by the liver when it becomes fatty. They found a further group of proteins that were secreted by the liver – one month after starting a – which led to insulin resistance in skeletal muscle, a characteristic of early stage diabetes.

In data presented to a national scientific meeting recently – and currently being prepared for publication in an international journal – Professor Watt revealed that one of these proteins was particularly interesting in the cascade of physiological consequences of a .

"This proteins' role in the development of non-alcoholic is completely new," Professor Watt said. The research group found that this protein is increased in livers that are developing fatty liver disease, and that it may have a role in developing the condition.

Working with researchers in the Netherlands, Professor Watt tested the blood of patients with fatty liver disease and they found that they had raised levels of the proteins and that the level of protein was related to the level of insulin resistance (as an indicator of pre-diabetes).

Professor Watt believes blocking the could be a key to preventing the deadly consequences of obesity.

"We may be able to block the development of fatty liver disease and apply a hand brake to the development of diabetes," Professor Watt said.

Explore further: Reducing liver protein SIRT1 levels

Related Stories

Reducing liver protein SIRT1 levels

January 22, 2014
A new study led by Boston University School of Medicine (BUSM) demonstrates that the abnormal metabolism linked to obesity could be regulated in part by the interaction of two metabolic regulators, called the NAD-dependent ...

Liver disease may raise risk of heart problems, study says

June 24, 2013
(HealthDay)—A new study adds to growing evidence of a link between a common liver disease associated with obesity and high risk for heart disease.

Study discovers new regulators of the most prevalent liver disease

January 7, 2014
Excessive alcohol consumption, as well as obesity leads to the accumulation of fat in the liver, a disease termed fatty liver disease (FLD) or steatosis. FLD is one of the most prevalent diseases in Western societies and ...

Weight loss surgery alters fatty liver disease genes

August 6, 2013
Research has shown that weight loss surgery can benefit obese individuals in ways that go beyond shedding pounds, for example by causing early remission of type 2 diabetes. Now scientists have found that the surgery can also ...

New study identifies genes associated with unhealthy liver function

October 1, 2013
A groundbreaking study of nearly 2,300 extremely obese diabetes patients, led by the Translational Genomics Research Institute (TGen), has identified genes associated with unhealthy liver function.

Team unlocks secrets of diabetes drug: How and why metformin needs to interact with insulin to be effective

November 3, 2013
About 120 million people around the world with Type 2 diabetes – and two million in Canada – take the drug metformin to control their disease.

Recommended for you

Shaming overweight kids only makes things worse

November 20, 2017
(HealthDay)—Overweight kids who are shamed or stigmatized are more likely to binge eat or isolate themselves than to make positive changes such as losing weight, a leading pediatricians' group says.

Link between obesity and cancer is not widely recognized

November 17, 2017
A new study published in the Journal of Public Health has shown that the majority of people in the United Kingdom do not understand the connection between weight issues and cancer. Obesity is associated with thirteen types ...

Reversing negative effects of maternal obesity

November 8, 2017
A drug that increases energy metabolism may lead to a new approach to prevent obesity in children born to overweight mothers, UNSW Sydney researchers have found.

Serving water with school lunches could prevent child, adult obesity: study

November 7, 2017
Encouraging children to drink plain water with their school lunches could prevent more than half a million youths in the U.S. from becoming overweight or obese, and trim the medical costs and indirect societal costs associated ...

Why do some obese people have 'healthier' fat tissue than others?

November 1, 2017
One little understood paradox in the study of obesity is that overweight people who break down fat at a high rate are less healthy than peers who store their fat more effectively.

Engineered protein treatment found to reduce obesity in mice, rats and primates

October 19, 2017
(Medical Xpress)—A team of researchers with pharmaceutical company Amgen Inc. report that an engineered version of a protein naturally found in the body caused test mice, rats and cynomolgus monkeys to lose weight. In their ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

alexey_romanov_98892
not rated yet Feb 03, 2014
I want to be a living donor and I search for organ transplant recipient who is ready to pay well. I am ready to give one of my kidneys or part of my liver, but I want to receive a big compensation for that. I am 34 years old man. My blood is O+ and I have a good health. I don't smoke cigarettes and don't drink alcohol.
Contact me if you need kidney or liver transplant. If you don't need it, but you know somebody who need it, could you please send my message to this person or keep it. I understand it is not normal to ask money for organ donation, so it will be confidential between us. I am ready to make any tests to prove my health and send copies by e-mail. I will listen the offer and conditions of recipient. This is not a joke and I am not an organ broker or kind of that. I do it myself and I will do it.
alexukrainian@yandex.ua

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.